The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BWAY | +104.7% | +173.27% | +22.24% | +96% |
| S&P | +13.95% | +78.35% | +12.25% | +139% |
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
No news articles found for BrainsWay.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $13.58M | 28.9% |
| Gross Profit | $10.21M | 31.8% |
| Gross Margin | 75.19% | 1.7% |
| Market Cap | $285.92M | 85.5% |
| Market Cap / Employee | $2.38M | 0.0% |
| Employees | 120 | 0.0% |
| Net Income | $1.57M | 137.0% |
| EBITDA | $1.66M | 127.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $70.71M | 46.1% |
| Accounts Receivable | $5.13M | 45.7% |
| Inventory | 4.4 | 19.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $5.71M | 0.0% |
| Short Term Debt | $1.04M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 6.81% | 4.5% |
| Return On Invested Capital | -14.65% | 9.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $579.59K | -40.7% |
| Operating Free Cash Flow | $1.38M | -39.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 57.01 | 43.64 | 45.25 | 45.17 | -55.90% |
| Price to Book | 3.57 | 3.59 | 3.89 | 4.18 | 16.66% |
| Price to Sales | 4.31 | 4.11 | 5.35 | 5.79 | 45.89% |
| Price to Tangible Book Value | 3.57 | 3.59 | 3.89 | 4.18 | 16.66% |
| Price to Free Cash Flow TTM | 27.28 | 22.29 | 13.18 | 15.52 | -39.94% |
| Enterprise Value to EBITDA | 98.79 | 116.46 | 178.83 | 133.61 | -7.59% |
| Free Cash Flow Yield | 3.7% | 4.5% | 7.6% | 6.4% | 66.49% |
| Return on Equity | 5.6% | 7.4% | 9.7% | 11.1% | 213.51% |
| Total Debt | $5.62M | $5.57M | $6.13M | $6.75M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
